Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.40
Bid: 117.20
Ask: 138.00
Change: 0.00 (0.00%)
Spread: 20.80 (17.747%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 135.40
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

24 May 2018 12:44

RNS Number : 2150P
NCC Group PLC
24 May 2018
 

NCC Group plc

Sale of Software Testing

 

NCC Group plc (LSE: NCC, "NCC Group" or "the Group"), the independent global cyber security and risk mitigation expert, is today announcing the sale of its Software Testing business to QualiTest Group ('QualiTest'), a portfolio company of Marlin Equity Partners.

 

The Group has completed the sale of the Software Testing business to QualiTest Group for immediate cash consideration of £3.6m on a cash and debt free basis (subject to any final post-completion adjustments to working capital).

NCC Group's Strategic Review, which completed in July 2017, concluded that its Software Testing and Web Performance businesses had little strategic overlap with the Group's broader cyber security and business continuity activities and therefore would be sold. It was management's view that both businesses would benefit from operating within companies whose core activities were more closely aligned to their own. Following the sale of the Web Performance business on 28 March 2018, the sale of Software Testing therefore completes the divestment process enabling the Group to focus on its two core divisions, Assurance and Escrow.

 

QualiTest is the world's largest pure play software testing and quality assurance specialist. The acquisition of NCC Group's Software Testing division will significantly expand QualiTest's presence in the U.K. and the pooling of knowledge and expertise will enhance the service offering for all customers of the combined business.

 

At the end of April 2018, net assets attributable to the Software Testing business (which are subject to post-completion adjustments to working capital) amounted to £9.7m, which included £8.0m of goodwill from the original acquisition of Software Testing in 2009. In the eleven months to the end of April 2018, Software Testing contributed £0.7m of Adjusted EBIT(1) to the Group's performance.

Software Testing was designated as a discontinued activity in the Group's Interim results that were published on 16 January 2018, given the earlier decision to sell the business. The sale therefore has no impact on expected full year Adjusted EBIT from continuing activities and only an immaterial impact on total full year Adjusted EBIT. The cash proceeds will reduce the Group's net indebtedness.

The Group expects to report its full year results, for the year ended 31 May 2018 on Tuesday, 17 July 2018.

24 May 2018

(1) Adjusted EBIT excludes individually significant items, share based payments, unwinding of discounts on deferred consideration and amortisation of acquired intangible assets. For Software Testing specifically, it also includes an estimate of its fair share of attributable shared central overheads.

NCC Group

Enquiries:

NCC Group (www.nccgroup.trust)

+44 (0)161 209 5432

Adam Palser, CEO

Brian Tenner, CFO

 

Maitland

+44 (0) 207 379 5151

Neil Bennett / Al Loehnis

 

About NCC Group plc

Listed on the London Stock Exchange, NCC Group is a global expert in cyber security and risk mitigation, working with businesses to protect their brand, value and reputation against the ever-evolving threat landscape. With the company's knowledge, experience and global footprint, it is best placed to help businesses identify, assess, mitigate & respond to the risks they face.

 

Headquartered in Manchester, UK, NCC Group employs over 1,500 people globally and is a trusted advisor to more than 15,000 clients worldwide. https://www.nccgroup.trust/uk/

 

About QualiTest Group

 QualiTest is the world's largest pure play software testing and quality assurance specialist. QualiTest designs and delivers solutions that leverage deep industry-specific understanding with cutting-edge testing technology. QualiTest offers a wide range of personalized testing solutions with years of expertise in the technology, telecom, healthcare, finance, defence, media, utilities and retail industries. With offices in the United States, the United Kingdom, Israel and India, the company serves over 500 customers worldwide.

 

-- Ends --

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISUSSARWOAVUAR
Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.